New cervical cancer vaccine is welcomed
A new US-approved vaccine against cervical cancer has been welcomed by the Irish Cancer Society as a significant breakthrough.
The vaccine, called Gardasil, works by blocking certain types of human papilloma virus (HPV), a sexually transmitted disease that leads to most cases of cervical cancer.
John McCormack, chief executive of the Irish Cancer Society, has welcomed the vaccine as a step in the right direction.
‘‘We are in favour of any treatment which will prevent cancer and we hope that if it is approved by the EU regulatory authority it will be introduced here...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply